These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25046649)

  • 21. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
    Jacobson KA
    Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
    Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
    Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.
    Goddard WA; Kim SK; Li Y; Trzaskowski B; Griffith AR; Abrol R
    J Struct Biol; 2010 Apr; 170(1):10-20. PubMed ID: 20079848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
    Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards predictive docking at aminergic G-protein coupled receptors.
    Jakubík J; El-Fakahany EE; Doležal V
    J Mol Model; 2015 Nov; 21(11):284. PubMed ID: 26453085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based virtual screening discovers potent and selective adenosine A
    Matricon P; Nguyen AT; Vo DD; Baltos JA; Jaiteh M; Luttens A; Kampen S; Christopoulos A; Kihlberg J; May LT; Carlsson J
    Eur J Med Chem; 2023 Sep; 257():115419. PubMed ID: 37301076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
    Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V
    J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
    Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A
    Falsini M; Ceni C; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Martí Navia A; Volpini R; Colotta V
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127126. PubMed ID: 32241719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine A2A receptor agonists: CoMFA-based selection of the most predictive conformation.
    Doytchinova I; Valkova I; Natcheva R
    SAR QSAR Environ Res; 2002 Mar; 13(2):227-35. PubMed ID: 12071651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
    Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
    J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling study on potent and selective adenosine A(3) receptor agonists.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
    Bioorg Med Chem; 2010 Nov; 18(22):7923-30. PubMed ID: 20943397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
    Pang X; Yang M; Han K
    Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.